sitagliptin glenmark 50 mg
glenmark arzneimittel gmbh - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 50 mg
sitagliptin glenmark 25 mg
glenmark arzneimittel gmbh - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 25 mg
sitagliptin glenmark 100 mg
glenmark arzneimittel gmbh - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 100 mg
sitagliptin hexal 50 mg
hexal a/s - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 50 mg
sitagliptin hexal 25 mg
hexal a/s - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 25 mg
sitagliptin hexal 100 mg
hexal a/s - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 100 mg
teriflunomide mylan
mylan pharmaceuticals limited - teriflunomide - multippel sklerose, relapsing-remitting - immunsuppressive - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
teriflunomide accord
accord healthcare s.l.u. - teriflunomide - multippel sklerose, relapsing-remitting - immunosuppressants, selektiv immunosuppressants - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
sitagliptin sandoz 25 mg
sandoz - københavn - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 25 mg
sitagliptin sandoz 50 mg
sandoz - københavn - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 50 mg